D-0871-2026 Class II Ongoing
FDA drug recall D-0871-2026 was initiated by Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare Company on Sep 15, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing.
Recall Details
- Product Type
- Drugs
- Report Date
- Sep 30, 2026
- Initiation Date
- Sep 15, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
Product Description
Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with Hang Tag, 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Nationwide in the USA.
Code Information
Lot #: RL25G04, Exp. Date 07/2027; RL2H02, Exp. Date 08/2027.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0871-2026
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 24, 2026